Home News UAE Launches Genomics-Based Alzheimer's Prevention Trial

UAE Initiates Genomics-Based Alzheimer's Prevention Trial

Jun 30, 2026
81 min
7
Jun 30, 2026 17:31
UAE launches first genomics-driven clinical trial to prevent Alzheimer's

## Pioneering Genomics Trial in Abu Dhabi

The United Arab Emirates has launched its first clinical trial aimed at preventing Alzheimer's disease using genomics. This initiative, driven by the Emirati Genome Programme, is a collaboration between M42’s Insights Research Organization and Solutions (IROS), the Department of Health – Abu Dhabi, and Halia Therapeutics, a US-based biotech firm.

## Focus on Early Detection

The trial seeks to identify individuals at high risk for Alzheimer's before symptoms emerge by utilizing genomic data. Participants will be screened for the APOE4 gene variant, a significant genetic marker for late-onset Alzheimer's. This approach aims to shift healthcare towards prevention-focused strategies.

## Regulatory and Ethical Oversight

The Department of Health – Abu Dhabi is overseeing the trial, ensuring compliance with data protection and patient privacy regulations. Eligible participants will be invited for screening through targeted outreach efforts.

## Advancing Precision Medicine

Dr. Noura Al Ghaithi from the Department of Health highlighted the Emirati Genome Programme's role in transforming healthcare by integrating genomic data into clinical research. This trial exemplifies the UAE's commitment to personalized healthcare and early risk detection.

## Global Implications

Alzheimer’s disease affects over 55 million people worldwide, with numbers expected to rise significantly. The UAE's genomic resources, which include over 900,000 sequenced genomes, provide a robust foundation for advancing precision medicine and addressing global health challenges.

## Halia Therapeutics' Role

Halia Therapeutics is focusing on genetic resilience to develop therapies that enhance natural resistance to Alzheimer's. Their investigational therapy, HT-4253, targets pathways associated with the disease's progression, marking a significant step in prevention-focused neurological research.

## Abu Dhabi as a Biotech Hub...

Read the full story at the source

What you need to know to get Emirates ID?

Leave your details and get a guide as a gift to avoid mistakes

Guide illustration
Article contents